Larvol Delta - The-efficacy-and-safety-of-a-selective-PARP1-inhibitor-ACE86225106-in-patients-with-advanced-solid-tumors-Preliminary-results-from-a-firstinhuman-phase-12-study

IMC001 - Immunofoco

ACE-86225106 - Acerand Therap

https://meetings.asco.org/abstracts-presentations/250291/

Jiongjie Chen; Jian Zhang; Zhanhong Chen; Yu Chen

May 2, 2025

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next